Eton Pharmaceuticals (ETON) Enterprise Value (2019 - 2025)
Historic Enterprise Value for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to -$37.1 million.
- Eton Pharmaceuticals' Enterprise Value fell 8321.41% to -$37.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$37.1 million, marking a year-over-year decrease of 8321.41%. This contributed to the annual value of -$14.9 million for FY2024, which is 3016.64% up from last year.
- As of Q3 2025, Eton Pharmaceuticals' Enterprise Value stood at -$37.1 million, which was down 8321.41% from -$25.4 million recorded in Q2 2025.
- Eton Pharmaceuticals' Enterprise Value's 5-year high stood at -$13.4 million during Q3 2022, with a 5-year trough of -$37.1 million in Q3 2025.
- In the last 5 years, Eton Pharmaceuticals' Enterprise Value had a median value of -$17.7 million in 2024 and averaged -$20.0 million.
- Per our database at Business Quant, Eton Pharmaceuticals' Enterprise Value plummeted by 20972.45% in 2021 and then soared by 4108.94% in 2022.
- Eton Pharmaceuticals' Enterprise Value (Quarter) stood at -$14.4 million in 2021, then decreased by 13.18% to -$16.3 million in 2022, then tumbled by 31.17% to -$21.4 million in 2023, then skyrocketed by 30.17% to -$14.9 million in 2024, then crashed by 148.53% to -$37.1 million in 2025.
- Its Enterprise Value was -$37.1 million in Q3 2025, compared to -$25.4 million in Q2 2025 and -$17.4 million in Q1 2025.